Use of Beta Cyclodextrin to Remove Cholesterol and Increase Astaxanthin Content in Shrimp Oil
Navaneethan Raju,Soottawat Benjakul
DOI: https://doi.org/10.1002/ejlt.201900242
2019-10-21
European Journal of Lipid Science and Technology
Abstract:<p>Shrimp oil was extracted from shrimp (<i>Litopenaeus vannamei</i>) cephalothorax and subjected to the removal of cholesterol by beta cyclodextrin (βCD). Different oil/ βCD ratios (1:2, 1:3 and 1:4, w/w) and homogenization times (1, 10, and 20 min) were used. Cholesterol deduction was attained with increasing βCD levels and homogenization time. Astaxanthin content was augmented, while cholesterol concentration was reduced. Nevertheless, oil yield and astaxanthin concentration of treated oil were decreased as βCD levels were increased. To increase the oil yield, the used βCD was further extracted for three times with ethyl acetate at 1:10 (w/v) ratio, in which yield was increased from 44.6% to 64%. Cholesterol removal of 95% was obtained, while astaxanthin content was increased. Lipid oxidation was lowered as indicated by the lower TOTOX value, peroxide value, TBARS and p‐Anisidine value. However, lipid hydrolysis was slightly increased after treatment. Volatiles, especially aldehydes and alcohols, were decreased after treatment. FTIR spectra confirmed the removal of phospholipid, which might be associated with the decreased oil yield after treatment. With the developed process, total fatty acid was increased by 15.6%, in which MUFA and PUFA were augmented. βCD could remove cholesterol, increase astaxanthin and fatty acid content.</p><p><i>Practical applications</i>: Shrimp oil has been known to be a rich source of astaxanthin and polyunsaturated fatty acids with health benefit. However, it also contains cholesterol, which can be a drawback for consumption as the supplement. The removal of cholesterol, while maintaining PUFA and astaxanthin could pave a way for promoting the intake of shrimp oil. Use of β‐cyclodextrin for oil treatment with subsequent extraction of remaining oil in the used β‐cyclodextrin could be implemented with ease. Another advantage of the developed process was to increase both fatty acid and astaxanthin contents in the resulting oil. As a consequence, shrimp oil with lowered cholesterol can be directly used as food ingredient and also for neutraceutical purpose.</p><p>This article is protected by copyright. All rights reserved</p>
food science & technology,nutrition & dietetics